Glen Eagle Advisors, LLC Medtronic PLC Transaction History

Glen Eagle Advisors, LLC

$546 Billion
Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 8,068 shares of MDT stock, worth $712,081. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,068

Previous 10,204 20.93%

Holding current value

$712,081

Previous $819 Million 22.42%

% of portfolio

0.12%

Previous 0.68%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$78.71 - $87.02 $168,124 - $185,874	-2,136 Reduced 20.93%	8,068 $635 Million
Q1 2024 Jul 03, 2024	BUY	$82.84 - $88.09 $655,927 - $697,496	7,918 New	7,918 $690 Million
Q4 2023 Aug 13, 2024	SELL	$69.43 - $83.43 $42,560 - $51,142	-613 Reduced 7.09%	8,027 $661 Million
Q3 2023 Aug 13, 2024	SELL	$78.22 - $90.4 $9,777 - $11,300	-125 Reduced 1.43%	8,640 $677 Million
Q2 2023 Aug 13, 2024	SELL	$79.47 - $91.38 $21,695 - $24,946	-273 Reduced 3.02%	8,765 $772 Million
Q1 2023 Aug 13, 2024	SELL	$76.72 - $87.58 $192,490 - $219,738	-2,509 Reduced 21.73%	9,038 $729 Million
Q4 2022 Aug 13, 2024	SELL	$76.18 - $87.74 $43,574 - $50,187	-572 Reduced 4.72%	11,547 $897 Million
Q3 2022 Aug 13, 2024	SELL	$80.75 - $95.31 $47,319 - $55,851	-586 Reduced 4.61%	12,119 $979 Million
Q2 2022 Aug 13, 2024	BUY	$87.4 - $113.09 $10,313 - $13,344	118 Added 0.94%	12,705 $1.14 Billion
Q1 2022 Aug 13, 2024	BUY	$100.58 - $112.38 $95,048 - $106,199	945 Added 8.12%	12,587 $1.4 Billion
Q4 2021 Aug 13, 2024	SELL	$99.53 - $127.75 $51,954 - $66,685	-522 Reduced 4.29%	11,642 $1.2 Billion
Q3 2021 Aug 13, 2024	SELL	$122.75 - $135.17 $19,885 - $21,897	-162 Reduced 1.31%	12,164 $1.52 Billion
Q2 2021 Aug 13, 2024	BUY	$118.19 - $131.5 $16,664 - $18,541	141 Added 1.16%	12,326 $1.53 Billion
Q1 2021 Aug 13, 2024	SELL	$111.18 - $119.74 $60,259 - $64,899	-542 Reduced 4.26%	12,185 $1.44 Billion
Q4 2020 Aug 13, 2024	BUY	$100.57 - $117.14 $483,641 - $563,326	4,809 Added 60.74%	12,727 $1.49 Billion
Q3 2020 Aug 13, 2024	SELL	$90.13 - $108.78 $20,549 - $24,801	-228 Reduced 1.74%	12,869 $1.34 Billion
Q2 2020 Aug 13, 2024	BUY	$84.11 - $103.33 $39,447 - $48,461	469 Added 3.71%	13,097 $1.2 Billion
Q1 2020 Aug 13, 2024	SELL	$72.92 - $121.3 $182,956 - $304,341	-2,509 Reduced 16.58%	12,628 $1.14 Billion
Q4 2019 Aug 13, 2024	BUY	$104.49 - $114.54 $343,876 - $376,951	3,291 Added 27.78%	15,137 $1.72 Billion
Q3 2019 Aug 13, 2024	BUY	$98.02 - $111.18 $27,445 - $31,130	280 Added 2.42%	11,846 $1.29 Billion
Q2 2019 Aug 13, 2024	SELL	$84.15 - $99.38 $8,330 - $9,838	-99 Reduced 0.85%	11,566 $1.13 Billion
Q1 2019 Aug 13, 2024	BUY	$82.45 - $93.79 $308,940 - $351,431	3,747 Added 47.32%	11,665 $1.06 Billion
Q4 2018 Aug 13, 2024	BUY	$85.8 - $99.49 $2,831 - $3,283	33 Added 0.29%	11,295 $1.03 Billion
Q3 2018 Aug 13, 2024	BUY	$85.91 - $99.17 $39,260 - $45,320	457 Added 4.23%	11,262 $1.11 Billion
Q2 2018 Aug 13, 2024	SELL	$77.48 - $87.83 $35.1 Million - $39.7 Million	-452,379 Reduced 97.67%	10,805 $925 Million
Q1 2018 Aug 14, 2024	BUY	$76.55 - $87.26 $174,993 - $199,476	2,286 Added 28.87%	10,204 $819 Million
Q1 2018 Aug 13, 2024	BUY	$76.55 - $87.26 $34.7 Million - $39.5 Million	452,800 Added 4360.55%	463,184 $819 Million
Q4 2017 Aug 13, 2024	BUY	$76.93 - $83.5 $114,548 - $124,331	1,489 Added 16.74%	10,384 $838 Million
Q3 2017 Aug 13, 2024	BUY	$77.71 - $84.6 $75,922 - $82,654	977 Added 12.34%	8,895 $692 Million
Q2 2017 Aug 12, 2024	BUY	N/A	177 Added 1.4%	12,831 $1.14 Billion
Q1 2017 Aug 12, 2024	BUY	N/A	811 Added 6.85%	12,654 $1.02 Billion
Q4 2016 Aug 12, 2024	BUY	N/A	3,925	11,843 $844 Million

Others Institutions Holding MDT

# of Institutions

2,222

Shares Held

1.04B

Call Options Held

7.09M

Put Options Held

4.39M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Medtronic PLC Transaction History